Summary of Significant Accounting Policies - Additional Information (Details)		3 Months Ended
	Mar. 25, 2022 USD ($) Market	Mar. 31, 2023 USD ($) Segment ReportingUnits Institution Customer Market	Mar. 31, 2022 USD ($)
Segment and Geographic Information
Number of operating segments | Segment		1
Cash Equivalents
Cash Equivalents		$ 246,500,000
Concentration of Credit Risk
Number of financial institutions that hold the Company's cash | Institution		2
Business Combination
Intangible assets, Estimated period of benefit		9 years
Number of reporting units | ReportingUnits		1
Accounts Receivable, net
Accounts receivable, Allowance for credit loss		$ 0
Number of customers | Customer		3
Equipment, net
Estimated useful life		3 years
Cost of Product Sales
Payment terms		90 days or less
Advertising costs		$ 21,400,000
Income Taxes
Income tax expense		$ 2,580,000
'Customer Concentration Risk | Accounts Receivable | Customer One
Accounts Receivable, net
Concentration risk, percentage		47.00%
'Customer Concentration Risk | Accounts Receivable | Customer Two
Accounts Receivable, net
Concentration risk, percentage		24.00%
'Customer Concentration Risk | Accounts Receivable | Customer Three
Accounts Receivable, net
Concentration risk, percentage		24.00%
License Fee
Cost of Product Sales
Cost of product sales		$ 5,000,000.0
Ex-U.S. Markets
Cost of Product Sales
Sales		1,700,000
Sunosi
Cost of Product Sales
Cost of product sales		2,600,000
Sales		12,900,000
Prior period adjustments for product sales resulting from changes in estimates		$ (300,000)
Number of Asian markets | Market		12
Revenue milestones	$ 165,000,000	$ 165,000,000
Development milestones	$ 1,000,000	1,000,000
Auvelity
Cost of Product Sales
Cost of product sales		2,600,000
Sales		15,700,000
Prior period adjustments for product sales resulting from changes in estimates		$ 700,000
License agreement royalty as a percent of net sales		3.00%
Product Sales | License Fee
Cost of Product Sales
Cost of product sales			$ 0
Jazz Pharmaceuticals Plc | Sunosi
Business Combination
Intangible assets, Estimated period of benefit		10 years
Cost of Product Sales
Number of Asian markets | Market	12